MGLDX | MGLMX | MGLDX / MGLMX | |
Total Expense Ratio | 1.94 | 0.94 | 206% |
Annual Report Gross Expense Ratio | 1.95 | 0.95 | 205% |
Fund Existence | 10 years | 10 years | - |
Gain YTD | 2.096 | 2.491 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.28B | 2.28B | 100% |
Annual Yield % from dividends | 1.17 | 2.53 | 46% |
Returns for 1 year | 2.38 | 3.36 | 71% |
Returns for 3 years | -11.96 | -9.31 | 129% |
Returns for 5 years | 5.77 | 11.23 | 51% |
Returns for 10 years | 9.32 | 23.17 | 40% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PSSIX | 23.82 | N/A | N/A |
Principal SmallCap S&P 600 Index Inst | |||
JNGLX | 65.49 | N/A | N/A |
Janus Henderson Global Life Sciences D | |||
TEOOX | 9.19 | N/A | N/A |
Transamerica Emerging Markets Eq R6 | |||
SIEYX | 13.68 | N/A | N/A |
Saratoga International Equity A | |||
VLIIX | 13.28 | -0.07 | -0.52% |
Value Line Capital Appreciation Instl |